Literature DB >> 1373666

Identification of metastatic disease by T category, gleason score and serum PSA level in patients with carcinoma of the prostate.

A Rana1, K Karamanis, M G Lucas, G D Chisholm.   

Abstract

Pre-operative serum prostate specific antigen (Tandem-R assay), T category, Gleason score and the metastatic (M1) status of a consecutive series of 60 patients with newly diagnosed carcinoma of the prostate were studied prospectively. The results revealed that, of these variables, pre-operative serum PSA (greater than 100 ng/ml) was the single most important indicator of metastatic disease, with 100% predictive value. With this alone, 83.3% of M1 disease could be correctly identified. For the remaining 17%, however, we advocate a high index of suspicion if the tumour is T3-T4 category on digital rectal examination (predictive value = 71.4%) and has a high grade with a Gleason score 8-10 (predictive value = 81%).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373666     DOI: 10.1111/j.1464-410x.1992.tb15528.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  3 in total

1.  Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?

Authors:  Bertrand Tombal; Frederic Lecouvet
Journal:  Adv Urol       Date:  2011-10-16

2.  Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study.

Authors:  Frederik B Thomsen; Marcus Westerberg; Hans Garmo; David Robinson; Lars Holmberg; Hans David Ulmert; Pär Stattin
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

3.  C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk.

Authors:  C M Eklund; T L J Tammela; J Schleutker; M Hurme
Journal:  Br J Cancer       Date:  2009-05-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.